Skip to content

Insmed INSM Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$1.18B+7.3%-$1.28B-7.9%-$1.18B-14.5%-$1.03B-2.1%-$1.01B-10.9%
$11.5M+10.1%$10.45M+25.8%$8.3M+13.7%$7.3M+16.8%$6.26M+4.9%
$159.2M+4.3%$152.71M+8.9%$140.23M+4.4%$134.34M+17.2%$114.65M+18.4%
-$895.66M+4.2%-$935.01M-5.8%-$883.4M-4.6%-$844.55M-10.8%-$761.94M-11.4%
$25.97M-20.2%$32.56M+43.2%$22.74M-5.3%$24.02M-12.1%$27.31M+24.6%
$954.59M+0.1%$954.07M-11.6%$1.08B-25.2%$1.44B+5.6%$1.37B+1.9%
-$126.69M-438%$37.53M+119%-$192.48M-365%
-$921.64M+4.7%-$967.58M-6.8%-$906.14M-4.3%-$868.57M-10.0%-$789.25M-11.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Insmed generate?
Insmed (INSM) generated -$895.7M in operating cash flow over the trailing twelve months.
What is Insmed's free cash flow?
After $26.0M of capital expenditures, Insmed's free cash flow was -$921.6M over the trailing twelve months, down 16.8% year over year.
Where does Insmed's cash flow data come from?
Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.